We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Congress Receives FDA’s User Fee Reauthorization Recommendations
Congress Receives FDA’s User Fee Reauthorization Recommendations
The HHS secretary recently delivered FDA’s recommendations for reauthorizing user fees covering prescriptions, generic drugs and biosimilars to Congress, before the body begins to craft a legislative package due by the end of September.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor